| SECTOR | INDUSTRY |
| Health Care | Biotechnology |
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
Cynthia McLaughlin
Michael Rose
Michael Rose
Omar Beirat
Jenna Brashear
| Share Statistics | BBOT | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $373.6 | $271.9 | 34% |
|
| Shares Out (Mil) | 80.1 | 54.2 | 58% |
|
| Institutional Ownership | 100.0% | 92.9% | 99% |
|
| Float (Mil) | 35.8 | 42.1 | 39% |
|
| Beta | 0.39 | 0.95 | 22% |
|
| Avg Daily Volume (000s) | 1,099 | 612 | 70% |
|
| Price Change (52-week) |
(59.2%) | 56.0% | 13% |
|
| Growth | BBOT | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | na | 13.1% | na |
|
| Net Income (5yr) | na | (10.1%) | na |
|
| EPS (5yr) | na | 15.7% | na |
|
| Dividends (5yr) | na | 0.0% | na |
|
| Cash Flow (5yr) | na | (15.6%) | na |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 10 | 11 | 10 | |
| Current EPS | ($0.659) | ($2.845) | ($2.716) | |
| Month Ago EPS | ($0.660) | ($2.682) | ($2.412) | |
| # Rev Up | 0 | 0 | 0 | |
| # Rev Down | 1 | 1 | 1 | |
| Three Months Ago EPS | ($0.563) | ($2.232) | ($2.125) | |
| Year/Year Chg | (6.5%) | (33.9%) | (43.8%) | |
| Financials | BBOT | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | na | $37 | na |
|
| Net Income (TTM) (Mil) | ($182) | ($43) | 7% |
|
| EPS (TTM) | ($2.559) | ($1.500) | 13% |
|
| Operating Cash Flow (TTM) (Mil) | ($151) | ($32) | 5% |
|
| Net Cash Flow (TTM) (Mil) | $23 | $2 | 63% |
|
| Long-Term Debt (Q1) (Mil) | $2 | $4 | 20% |
|
| Enterprise Value (Q1) (Mil) | $55 | $177 | 17% |
|
| Valuation | BBOT | Industry Median |
Percentile (All Stocks) |
|
| P/B | 1.16 | 2.67 | 28% |
|
| P/E | na | 19.5 | na |
|
| Dividend Yield | na | 0.0% | na |
|
| PEG (5yr hist) | na | 1.0 | na |
|
| Ratios | BBOT | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | na | 69.0% | na |
|
| Net Margin | na | (71.5%) | na |
|
| ROA | (69.0%) | (47.4%) | 9% |
|
| ROE | (381.9%) | (54.6%) | 2% |
|
| Liabilities to Assets | 14.2% | 29.3% | 9% |
|
| F-Score | 1 | 3 | na |
|
Passing Stock Screens
As of 9/22/2026, from a list of 60 stock screening strategies,
| Performance Since Inception: | 3.3% |
| +/- S&P 500: | -4.2 |
| Performance Since Inception: | 2.8% |
| +/- S&P 500: | -4.7 |
Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.
Ⓒ 2026 American Association of Individual Investors
